The outcome of tuberculosis treatment after implementation of the national tuberculosis control program in Saudi Arabia

Annals of Saudi Medicine

Volumn 20, Issue 2, 2000, Pages 125-128

  Al Hajjaj, M S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Control; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ARTICLE; CONTROLLED STUDY; DEATH; ENDEMIC DISEASE; FEMALE; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RELAPSE; SAUDI ARABIA; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

EID: 0034508664     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2000.125     Document Type: Article

References (24)

1. Tuberculosis in Saudi Arabia
2. Review of tuberculosis in Saudi Arabia
3. Nationwide community survey of tuberculosis epidemiology in Saudi Arabia
4. Treatment of tuberculosis as adopted by the Saudi national tuberculosis control program committee
5. Treatment of tuberculosis and tuberculosis infection in adults and children
6. High rate of rifampicin resistance of Mycobacterium tuberculosis in the Taif region of Saudi Arabia
7. Compliance with tuberculosis therapy
8. When tuberculosis treatment fails. A social behavioral account of patient adherence
9. Factors associated with compliance in treatment of tuberculosis
10. High proportion of multi-drug resistant Mycobacterium tuberculosis in Saudi Arabia
11. Patient compliance with tuberculosis treatment in Ghana: Factors influencing adherence to therapy in a rural service programme
12. Defaults, defaulter action and retrieval of patients during studies on tuberculous meningitis in children
13. Strategies to improve compliance with therapy
14. The problem of non-attendance at a pediatric tuberculosis outpatient clinic
15. Universal directly observed therapy. A treatment strategy for tuberculosis
16. Directly observed therapy, patient education and combined drug formulations: Complementary, not alternative, strategies in tuberculosis control
17. Implementation of universal directly observed therapy at a New York City hospital and evaluation of an out-patient directly observed therapy program
18. Evaluation of a directly observed six months fully intermittent treatment regimen for tuberculosis in patients suspected of poor compliance
19. Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis
20. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis
21. A cost-effectiveness analysis of directly observed therapy vs. self-administered therapy for treatment of tuberculosis
22. Non-compliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment